Efficacy Levels of Recombinant Tetravalent Dengue Vaccine (Cyd-Tdv) in Children Aged 2-16 Years: Meta-Analysis. JISIP [Internet]. 2024 Jun. 30 [cited 2026 Jun. 26];8(3):1583-91. Available from: https://ejournal.mandalanursa.org/index.php/JISIP/article/view/6988